BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35986430)

  • 1. YAP1-MAML2 fusion in a pediatric NF2-wildtype intraparenchymal brainstem schwannoma.
    Karajannis MA; Li BK; Souweidane MM; Liechty B; Yao J; Benhamida JK; Bale TA; Rosenblum MK
    Acta Neuropathol Commun; 2022 Aug; 10(1):117. PubMed ID: 35986430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical Intraparenchymal Meningioma with YAP1-MAML2 Fusion in a Young Adult Male: A Case Report and Mini Literature Review.
    Nobee A; Xu M; Seth A; Rong Y
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both YAP1-MAML2 and constitutively active YAP1 drive the formation of tumors that resemble NF2 mutant meningiomas in mice.
    Szulzewsky F; Arora S; Arakaki AKS; Sievers P; Almiron Bonnin DA; Paddison PJ; Sahm F; Cimino PJ; Gujral TS; Holland EC
    Genes Dev; 2022 Aug; 36(13-14):857-70. PubMed ID: 36008139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling YAP fusions: a paradigm for investigating rare cancers?
    Sahebjam S; Gilbert MR
    Genes Dev; 2022 Aug; 36(15-16):874-875. PubMed ID: 36207139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood Meningiomas.
    Schieffer KM; Agarwal V; LaHaye S; Miller KE; Koboldt DC; Lichtenberg T; Leraas K; Brennan P; Kelly BJ; Crist E; Rusin J; Finlay JL; Osorio DS; Sribnick EA; Leonard JR; Feldman A; Orr BA; Serrano J; Vasudevaraja V; Snuderl M; White P; Magrini V; Wilson RK; Mardis ER; Boué DR; Cottrell CE
    Am J Surg Pathol; 2021 Mar; 45(3):329-340. PubMed ID: 33074854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Genetic Predisposition With Solitary Schwannoma or Meningioma in Children and Young Adults.
    Pathmanaban ON; Sadler KV; Kamaly-Asl ID; King AT; Rutherford SA; Hammerbeck-Ward C; McCabe MG; Kilday JP; Beetz C; Poplawski NK; Evans DG; Smith MJ
    JAMA Neurol; 2017 Sep; 74(9):1123-1129. PubMed ID: 28759666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric meningioma with a Novel MAML2-YAP1 fusion variant: a case report and literature review.
    Zheng X; Guo S; Liu D; Chu J; Li Y; Wang X; Zhang X; Song C; Huang Q
    BMC Pediatr; 2022 Dec; 22(1):694. PubMed ID: 36463108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metaplastic thymoma: a distinctive thymic neoplasm characterized by YAP1-MAML2 gene fusions.
    Vivero M; Davineni P; Nardi V; Chan JKC; Sholl LM
    Mod Pathol; 2020 Apr; 33(4):560-565. PubMed ID: 31641231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YAP1-fusions in pediatric NF2-wildtype meningioma.
    Sievers P; Chiang J; Schrimpf D; Stichel D; Paramasivam N; Sill M; Gayden T; Casalini B; Reuss DE; Dalton J; Pajtler KW; Hänggi D; Herold-Mende C; Rushing E; Korshunov A; Mawrin C; Weller M; Schlesner M; Wick W; Jabado N; Jones DTW; Pfister SM; von Deimling A; Ellison DW; Sahm F
    Acta Neuropathol; 2020 Jan; 139(1):215-218. PubMed ID: 31734728
    [No Abstract]   [Full Text] [Related]  

  • 10. The neurofibromatosis type 2 gene is inactivated in schwannomas.
    Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA
    Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cases of Mixed Schwannoma-Meningioma With and Without Neurofibromatosis 2 with Emphasis on Tumorigenesis.
    Rajeswarie RT; Mallik D; Rudrappa S; Gopal S
    Int J Surg Pathol; 2024 May; 32(3):511-514. PubMed ID: 37487199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas.
    Antinheimo J; Sankila R; Carpén O; Pukkala E; Sainio M; Jääskeläinen J
    Neurology; 2000 Jan; 54(1):71-6. PubMed ID: 10636128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus.
    Sanson M; Marineau C; Desmaze C; Lutchman M; Ruttledge M; Baron C; Narod S; Delattre O; Lenoir G; Thomas G
    Hum Mol Genet; 1993 Aug; 2(8):1215-20. PubMed ID: 8401504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis.
    Bachir S; Shah S; Shapiro S; Koehler A; Mahammedi A; Samy RN; Zuccarello M; Schorry E; Sengupta S
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri.
    van den Munckhof P; Christiaans I; Kenter SB; Baas F; Hulsebos TJ
    Neurogenetics; 2012 Feb; 13(1):1-7. PubMed ID: 22038540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteasomal pathway inhibition as a potential therapy for NF2-associated meningioma and schwannoma.
    Bhattacharyya S; Oblinger JL; Beauchamp RL; Yin Z; Erdin S; Koundinya P; Ware AD; Ferrer M; Jordan JT; Plotkin SR; Xu L; Chang LS; Ramesh V
    Neuro Oncol; 2023 Sep; 25(9):1617-1630. PubMed ID: 36806881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of YAP1 C-terminus expression as an ancillary marker for metaplastic thymoma: a potential pitfall in detecting YAP1::MAML2 gene rearrangement.
    Wang X; Liu LL; Li Q; Xia QY; Li R; Ye SB; Zhang RS; Fang R; Chen H; Wu N; Rao Q
    Histopathology; 2023 Nov; 83(5):798-809. PubMed ID: 37565303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Meningiomas as a Criterion for the Diagnosis of Neurofibromatosis Type 2 and Other Tumor Predisposition Syndromes.
    Hannan CJ; Hammerbeck-Ward C; Pathmanaban ON; Smith MJ; Rutherford SA; Lloyd SK; Mackenzie Freeman SR; Wallace AJ; King AT; Richard Evans DG
    Neurosurgery; 2022 Jun; 90(6):793-799. PubMed ID: 35343466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma.
    Harada T; Irving RM; Xuereb JH; Barton DE; Hardy DG; Moffat DA; Maher ER
    J Neurosurg; 1996 May; 84(5):847-51. PubMed ID: 8622160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas.
    Mérel P; Hoang-Xuan K; Sanson M; Moreau-Aubry A; Bijlsma EK; Lazaro C; Moisan JP; Resche F; Nishisho I; Estivill X
    Genes Chromosomes Cancer; 1995 Jul; 13(3):211-6. PubMed ID: 7669741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.